October 21, 2026

ADHD Increases Risk of Early Death: A New Study

A recent review in JAMA Network Open reveals that individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) have a 71% higher risk of early death compared to those without the condition. This finding emphasizes the serious health implications associated with ADHD. However, taking prescription ADHD medication could reduce the overall mortality risk, offering a protective benefit.

Study Overview

Researchers analyzed data from 19 observational studies that included almost 16 million individuals across three continents. The focus was on understanding the long-term effects linked to ADHD.

Causes of Increased Mortality

The review looked at both unnatural causes such as injuries and suicide, and natural causes including diseases like cardiovascular ailments and diabetes. Across all types, individuals with ADHD showed higher mortality rates.

We found that people with ADHD face an increased risk not only of death by suicide and injury, but also of deaths by natural causes, adding to evidence that health inequalities faced by people with ADHD are broad and wide-ranging, said Joshua Stott, a professor at University College London.

More specifically, the risk of death from suicide nearly doubled, showing an 89% increase. There was also a 55% higher risk of dying from injuries and a 27% higher risk from natural causes for those with ADHD.

Health Risks and Medication Benefits

Natural cause mortality risks often involved long-term health challenges like smoking and substance usage. These individuals often struggle with managing chronic conditions. However, medication seems to lower the mortality risk by 25%, indicating it may alleviate some associated health risks.

ADHD is not by definition a life-limiting condition, Stott added. The right support and treatment can help people live long and healthy lives.

Access to an accurate diagnosis and treatment remains crucial for mitigating these risks.

Study Limitations

The research comes with limitations. All studies were observational, indicating associations rather than direct causations. Also, insights on ADHD medication originated from a subset of three studies, making these results preliminary.

Medication is just part of the story; many people with ADHD benefit from comprehensive, long-term treatment and support, stated Lucy Corrigan from the University of Liverpool.

As a result, more extensive research is needed to strengthen the understanding of the effect of medication on reducing mortality risks associated with ADHD.

TAGS: